Tatiana Yakovleva
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients.Churni Gupta, Chaejin Kim, Serge Guzy
|Mar 13, 2023
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes.Victor Sokolov, Tatiana Yakovleva, Leonid Stolbov
|Dec 28, 2020
A model-based approach to investigating the relationship between glucose-insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes.Millie Shah, Leonid Stolbov, Tatiana Yakovleva
|Aug 20, 2019
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors.Tatiana Yakovleva, Victor Sokolov, Lulu Chu
|Nov 21, 2018
Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitus.Victor Sokolov, Tatiana Yakovleva, Shinya Ueda
Pageof 1
Frequent Collaborators
4 joint publications
Victor Sokolov
4 joint publications
Robert C Penland
3 joint publications
David W Boulton
3 joint publications
Weifeng Tang
2 joint publications
Joanna Parkinson
2 joint publications
Leonid Stolbov
1 joint publications
Churni Gupta
1 joint publications
Stephan Schmidt
1 joint publications
Valvanera Vozmediano
1 joint publications
Shinya Ueda
